WELCOME ADDRESS
Time: 11:00-11:20
Topic: Live Long and Prosper. Diabetes Tech into the future
SPONSORED SESSION 1
Time: 8:40-9:10
Topic: Smart MDI, when monitoring may not be enough
Time: 11:00-11:20
Topic: Live Long and Prosper. Diabetes Tech into the future
PLENARY SESSION: Diabetes innovations today, for a better tomorrow
Time: 9:40-11:00
Topic: Exploring Diabetes Technologies: Unlocking the Opportunities and Addressing the Challenges
Time: 9:40-11:00
Topic: Exploring Diabetes Technologies: Unlocking the Opportunities and Addressing the Challenges
Time: 9:40-11:00
Topic: Exploring Diabetes Technologies: Unlocking the Opportunities and Addressing the Challenges
Time: 9:40-11:00
Topic: Exploring Diabetes Technologies: Unlocking the Opportunities and Addressing the Challenges
Time: 9:40-11:00
Topic: Exploring Diabetes Technologies: Unlocking the Opportunities and Addressing the Challenges
Time: 9:40-11:00
Topic: Exploring Diabetes Technologies: Unlocking the Opportunities and Addressing the Challenges
SPONSORED SESSION 2
Time: 11:30-12:00
Topic: Control-IQ Technology Made Easy: Achieving optimal and sustained outcomes with Automation and Customisation!
Time: 12:00-12:30
Topic: Time in range: Research to Reality
Time: 12:30-1:30
Topic: Seeing is believing : the added value of the data from a smart pen and CGM integration. Different patient segment case studies including FreeStyle Libre 2 and NovoPen 6.
The complexities and intricacies of diabetes technology
Time: 2:30-2:40
Topic:Diabetes technology selection – a model of care with a person-centred approach
Time: 2:40-3:00
Topic: Socio-economic, cultural and geographical barriers and disparities in diabetes care and technologies
Time: 3:00-3:20
Topic: Health System Responses to innovation and technologies
Time: 3:20-3:40
Topic: Healthcare navigation in a digitally connected world – does the hype live up to the reality?
Time: 2:40-3:00
Topic: Socio-economic, cultural and geographical barriers and disparities in diabetes care and technologies
Quick Bytes – Showcase of programs from diabetes services
Time: 4:35 – 4:40
Topic: PROM surveys with PERL: Improving survey workflows for Diabetes services
Time: 4:40 – 4:45
Topic: Improving carbohydrate counting education through digital health technology
Time: 4:45 – 4:50
Topic: Accessing funding for CGM technologies to assist in the daily management of residents with type 2 diabetes on MDI in a rural high level RACF
Time: 4:50 – 4:55
Topic: Promoting equitable access to continuous glucose monitoring for people with diabetes
Time: 2:40-3:00
Topic: Socio-economic, cultural and geographical barriers and disparities in diabetes care and technologies
Click here to download the program.
The National Association of Diabetes Centres (NADC) is a national collective of organisations that are involved either directly or indirectly in diabetes services and care.
Cheryl is a Registered Nurse with post graduate qualifications in Midwifery, Health Counselling and Diabetes Education. She is the manager of Diabetes Education Services at Western Health.
Her primary interests in diabetes education are insulin pumps, Continuous Glucose Monitoring Systems and Diabetes in Pregnancy. Cheryl has co-authored papers in peer reviewed journals on Type 1 diabetes and Gestational Diabetes. As well as her clinical role Cheryl has a strong focus on Health Professional education for nurses, allied health, medical practitioners and students.
Cheryl is a member of the clinical advisory committee for Diabetes Victoria. Cheryl lives with Type 1 diabetes which she manages with a the Ypsopump and CAM APS FX after swapping from her DIY loop system.
Live Long and Prosper. Diabetes Tech into the future. This presentation will explore what is on the horizon for diabetes technology.
Laura is an innovative clinician with 14+ years’ experience in chronic disease management and systems development. Having established a successful private Diabetes Specialty practice across QLD throughout Australia via telehealth, she is regarded as an expert in the education and management of patients across the full spectrum of diabetes, including insulin pumps and continuous glucose monitoring (CGM).
TBA
Tadej Battelino completed his medical degree at the University of Ljubljana in 1990. He completed a Masters degree, and later a PhD focusing on glucose metabolism in neonatal endotoxic shock in 1996. He completed his clinical fellowship at Loyola University of Chicago, and his postdoctoral fellowship at INSERM, Paris.
Tadej Battelino is currently Consultant and Head of Department of Pediatric and Adolescent Endocrinology, UMC Ljubljana, Head, Chair of Paediatrics, and Professor of Paediatrics at Faculty of Medicine, University of Ljubljana. He is PI on several research projects in the field of paediatric endocrinology and metabolism and was awarded the Slovene national award for research in 2014, and Gold medal for research at the University of Ljubljana in 2017. Professor Battelino is on the editorial boards for the journals Paediatric Diabetes,Journal of Pediatric Endocrinology and Metabolismand was Editor for the European Journal of Endocrinologyfrom 2009 to 2015. He has authored or co-authored over 200 manuscripts in international peer-reviewed journals and participated chapters to several books.
Tadej Battelino is a member of numerous professional associations including the European Society for Paediatric Endocrinology and the International Society for Pediatric and Adolescent Diabetes, for which he served as President for the 35thAnnual Congress. He served on the European Association for the Study of Diabetes (EASD) council and is co-organizer of eleven annual meetings of the ATTD (Advanced Technologies and Treatment of Diabetes). Professor Battelino is a regular member of the Slovene Medical Academy and the European Academy of Sciences and Arts.
TBA
Professor of Metabolic Medicine and Honorary Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust. He is Head of the Clinical Population and Sciences Department, local R&D lead for Diabetes/Endocrinology and regional clinical research network lead for Diabetes.
He is Deputy Chair of Clinical Study Group 2 at Diabetes UK, Associate Editor of Diabetes and Vascular Disease Research, member of the editorial board of International Journal of Molecular Sciences and member of the European Society of Cardiology working group on thrombosis.
He has over 240 publications including original and review articles, book chapters and books. Clinical practice concentrates on young adults with diabetes as well as older individuals with advanced vascular complications.
TBA
Laurel Messer (Ph.D., MPH, RN, CDCES) is a highly skilled and experienced healthcare professional with a strong background in diabetes technology, biobehavioral science, and public health.
Dr. Messer has extensive research experience trialing novel diabetes devices including insulin pumps, CGM, and automated insulin delivery. She is an expert in real-world use and passionate about understanding the user experience of people with diabetes. In addition to her technical expertise, Dr. Messer is an effective communicator and collaborator, with a proven track record of building and managing successful teams.
With over 70 published articles related to diabetes, Dr. Messer is a respected thought leader in the industry and a sought-after speaker at conferences and events. She is also the founder of the PANTHERProgram (http://PANTHERprogram.org, “Diabetes Technology. Deciphered”), a popular website for persons with diabetes and healthcare professionals interested in staying up-to-date on the latest technology.
She is currently the Senior Director, Translational Research & Applied Science at Tandem Diabetes Carel.
TBA
Jane was appointed as a Staff Specialist to Westmead Hospital in 1998 and is a Clinical Associate Professor of Sydney University. She was previously Chair of the Advanced training Committee in Endocrinology and on the Executive of the Australian Diabetes Society.
She manages > 300 people on insulin pump therapy across all age groups and the majority now use continuous glucose monitoring full time. She is one of the lead clinicians involved in islet cell transplant therapy for people with severe hypoglycemia unawareness since it was first performed in Australia in 2002 and she has supervised >150 islet transplant grafts. She is an investigator for the Australasian Diabetes Data Network which collects longitudinal data on youth and adults with type I diabetes across the life span including evaluation of the impact of CGM on diabetes care outcomes in Australia.
Australia has been well placed to pick up technology and insulin pumps – for instance one of the first to have access to automated insulin delivery and the 780G with lower glycemic targets- we have been and remain well ahead of USA and Canada
Insulin pumps with automation are now being used to address the challenges of management of glycemic levels in pregnancy with the Ypso device approved for pregnancy and the Medtronic 780G offering the lower glycemic target of 5.5
While we have addressed the inequities of access to CGM we need to build the financial argument to address access to insulin pump therapy now that automation of insulin delivery is revolutionising glycemic outcomes even for those with the highest HbA1c – need to build the cost benefit proposal for government to improve access. This might also pave the way for patch devices with the future omnipod 5 with automated insulin delivery to come soon
Dr Clark is a fellowed GP working in Townsville, Northern Queensland. He opened The Diabetic GP Clinic in 2017, which is a one-stop shop model of care clinic focused on chronic disease management in the primary care setting. This multidisciplinary care team clinic aims to provide patient centred management that is effective and convenient for those with chronic diseases.
Being a person with Type 1 Diabetes, Dr Clark has a passion for the care and management of Diabetes in general practice.
In 2022 he completed a MSc in Diabetes Care from the University of Warwick. This year he commenced his PhD investigating open-source technology in the management of type 1 diabetes.
TBA
Professor Elizabeth Davis has had a career of integrating clinical care and diabetes research based in Perth, Australia. She is the Head of the Department of Endocrinology and Diabetes at Perth Children’s Hospital (PCH) and co-directs the Children’s Diabetes Centre, a JDRF global centre of excellence, at the Telethon Kids Institute.
Professor Davis is a past President of the Australasian Paediatric Endocrine Group. She is on the leadership team at the Telethon Kids Institute and leads the Australasian hub of SWEET.
TBA
Laurel Messer (Ph.D., MPH, RN, CDCES) is a highly skilled and experienced healthcare professional with a strong background in diabetes technology, biobehavioral science, and public health.
Dr. Messer has extensive research experience trialing novel diabetes devices including insulin pumps, CGM, and automated insulin delivery. She is an expert in real-world use and passionate about understanding the user experience of people with diabetes. In addition to her technical expertise, Dr. Messer is an effective communicator and collaborator, with a proven track record of building and managing successful teams.
With over 70 published articles related to diabetes, Dr. Messer is a respected thought leader in the industry and a sought-after speaker at conferences and events. She is also the founder of the PANTHERProgram (http://PANTHERprogram.org, “Diabetes Technology. Deciphered”), a popular website for persons with diabetes and healthcare professionals interested in staying up-to-date on the latest technology.
She is currently the Senior Director, Translational Research & Applied Science at Tandem Diabetes Carel.
KEYPOINTS:
Tadej Battelino completed his medical degree at the University of Ljubljana in 1990. He completed a Masters degree, and later a PhD focusing on glucose metabolism in neonatal endotoxic shock in 1996. He completed his clinical fellowship at Loyola University of Chicago, and his postdoctoral fellowship at INSERM, Paris.
Tadej Battelino is currently Consultant and Head of Department of Pediatric and Adolescent Endocrinology, UMC Ljubljana, Head, Chair of Paediatrics, and Professor of Paediatrics at Faculty of Medicine, University of Ljubljana. He is PI on several research projects in the field of paediatric endocrinology and metabolism and was awarded the Slovene national award for research in 2014, and Gold medal for research at the University of Ljubljana in 2017. Professor Battelino is on the editorial boards for the journals Paediatric Diabetes,Journal of Pediatric Endocrinology and Metabolismand was Editor for the European Journal of Endocrinologyfrom 2009 to 2015. He has authored or co-authored over 200 manuscripts in international peer-reviewed journals and participated chapters to several books.
Tadej Battelino is a member of numerous professional associations including the European Society for Paediatric Endocrinology and the International Society for Pediatric and Adolescent Diabetes, for which he served as President for the 35thAnnual Congress. He served on the European Association for the Study of Diabetes (EASD) council and is co-organizer of eleven annual meetings of the ATTD (Advanced Technologies and Treatment of Diabetes). Professor Battelino is a regular member of the Slovene Medical Academy and the European Academy of Sciences and Arts.
Topic Key Points: CGM for detection of pre-T2D, CGM for diagnosis and for early intervention in T2D, CGM for remission of T2D
Professor of Metabolic Medicine and Honorary Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust. He is Head of the Clinical Population and Sciences Department, local R&D lead for Diabetes/Endocrinology and regional clinical research network lead for Diabetes.
He is Deputy Chair of Clinical Study Group 2 at Diabetes UK, Associate Editor of Diabetes and Vascular Disease Research, member of the editorial board of International Journal of Molecular Sciences and member of the European Society of Cardiology working group on thrombosis.
He has over 240 publications including original and review articles, book chapters and books. Clinical practice concentrates on young adults with diabetes as well as older individuals with advanced vascular complications.
TBA
Associate Professor Glynis Ross Associate Professor Glynis Ross is a Visiting Endocrinologist at Royal Prince Alfred Hospital, a Senior Staff Specialist at Bankstown-Lidcombe Hospital, and does regular outreach work in Central West NSW. Since 2016 she has been a Director on the Board of Diabetes Australia. Glynis has been the Lead Endocrinologist of the Diabetes and Pregnancy service at RPAH for over 30 years. Glynis was on the Australian Diabetes Society Council from 2012-2020 and is the immediate Past President. She was on the Australasian Diabetes in Pregnancy Society (ADIPS) Council for 2 x 8 year terms and was President 2008-2010.
Since 2013 she has chaired the NDSS Diabetes in Pregnancy Expert Reference Group and from 2004 has been a member of the national Diabetes Expert Advisory Group. Glynis is currently Chair of the ADS Education Advisory Council. In addition she is Chair of the NDSS Diabetes Expert Reference Group, a member of the NSW Diabetes and Endocrine Executive, national Diabetes Expert Advisory Group and involved in the National Diabetes Strategy.
Her major clinical and research interests are diabetes in pregnancy, type 1 diabetes, insulin pump therapy and inpatient diabetes management. She serves on a variety of other state and national working parties and in teaching programs for trainees in anaesthetics, obstetrics & gynaecology, physicians, midwives, general practitioners and medical undergraduates.
Continuous glucose monitoring (CGM) systems have been shown to be of great value for people living with type 1 diabetes of all ages.
There are clinical benefits for personal glycaemic management, confidence building and quality of life for those living with type 1 diabetes across all ages. There are potential benefits for their support network and direct carers. CGM data can guide better-informed management decisions by diabetes health professionals.
Until recently in Australia the cost burden has greatly limited use. However this has not been the only barrier to uptake and ongoing use of CGM so it is important to consider and understand other barriers to CGM use which may vary at different stages of life and need to be addressed.
Associate Professor Glynis Ross is a Visiting Endocrinologist at Royal Prince Alfred Hospital, and does regular outreach work in Central West NSW.
Since 2016 she has been a Director on the Board of Diabetes Australia. Glynis has been the Lead Endocrinologist of the Diabetes and Pregnancy service at RPAH for over 30 years. Glynis was on the Australian Diabetes Society Council from 2012-2020 (President 2018-2020). She was on the Australasian Diabetes in Pregnancy Society (ADIPS) Council for 2 x 8 year terms (President 2008-2010.) Since 2013 she has chaired the NDSS Diabetes in Pregnancy Expert Reference Group and from 2004 has been a member of the national Diabetes Expert Advisory Group.
Glynis is currently Chair of the ADS Education Advisory Council and a member of the ADS Advocacy Advisory Committee.
In addition she is Chair of the NDSS Diabetes Expert Reference Group, a member of the NADC Steering Committee, NADC Accreditation Committee, Living Evidence for Diabetes (LED) Steering Committee, LED In-Hospital Glycaemic Management Committee, LED Diabetes Technology Guidelines Group, NSW Diabetes and Endocrine Executive, national Diabetes Expert Advisory Group and involved in the National Diabetes Strategy.
Her major clinical and research interests are type 1 diabetes, diabetes technology, diabetes in pregnancy, inpatient diabetes management, and diabetes advocacy.
She serves on a variety of other state and national working parties and in teaching programs for trainees in anaesthetics, obstetrics & gynaecology, physicians, midwives, general practitioners and medical undergraduates.
“Health System Responses to Innovation and Technologies” Diabetes technology is rapidly advancing. This presents challenges for diabetes clinicians to stay uptodate with the technology and provide support to those living with diabetes to achieve maximal benefit from available systems for their individual needs. As well it is challenging for in-hospital diabetes services with need for updated local policies and guidelines as well as compatibility between the electronic medical record systems and diabetes technology downloads. Another consideration is funding support for the technology whether through Government or Private Health Insurance and the urgent need to strive for equity of access.
Toni Slotnes- O’Brien is a Senior Lecturer at UniSA and an endorsed Nurse Practitioner at UniSA City West Medical Clinic. Toni completed her nursing degree at the UniSA in 1993 and went on to pursue a Grad. certificate in Diabetes management in 2008 and a Master of Nurse Practitioner in 2013. She is currently studying a Grad. cert in mental health and a Master of Health and Clinical Research.
Toni holds the position of SA state chapter of the College of Nurse Practitioners and is Co- Chair of the International Council of Nurses NP education subgroup. She is also a committee member of the Australian NP academics collaborative and SA Health ED and older persons NP community of practice groups.
Healthcare navigation in a digitally connected world holds significant promise, but it’s essential to evaluate whether the hype surrounding it aligns with reality. This presentation will examine both aspects
As a registered nurse she saw the need for a more specialized Diabetes Education service within her community. She completed a post graduate certificate in Diabetes Education at Deakin University in 2001 and obtained credentialled status in 2006.
Prior to commencing employment at East Grampians Health Service (EGHS), she established and provided Diabetes Education Services in Private General Practice and Community Health in the Wimmera Region of Victoria.
She commenced in the role of Credentialled Diabetes Educator in December 2014 and advocated for increased diabetes education services within EGHS. Diabetes Education provides services to all clinical areas at EGHS and includes an outpatient service, outreach clinics to Elmhurst, Lake Bolac, Halls Gap, Hopkins Correctional Centre and Willaura.
With the support of EGHS, she have completed the Cert IV in Training and Assessment in 2019 and have been a sessional lecturer at Federation University TAFE for the Diploma of Nursing and have provided education sessions for clinical staff at EGHS.
She found it a privilege to be employed at EGHS and be part of the expansion of the Diabetes Education services offered to our community and I wish to thank EGHS for their ongoing support.
‘Accessing funding for CGM technologies to assist in the daily management of residents with type 2 diabetes on MDI in a rural high level RACF.’
Simone Patterson is a Credentialled Diabetes Educator and endorsed Nurse Practitioner, currently managing the Diabetes Education Service at Austin Health. She has completed post graduate qualifications including the Graduate Certificate of Diabetes Education in 2009, Master of Nursing Practice (Nurse Practitioner) in 2014 and Bachelor of Nursing (Honours) in 2019. Simone has worked in private practice, community health and hospital settings, providing diabetes education and management for both paediatric and adult people with diabetes and their families.
Simone is committed to health professional education to promote a culture that demonstrates a commitment to patient safety and innovative person-centred diabetes care. In 2019, she was awarded the inaugural Beverley Briese Nursing Scholarship to participate in the Global Observership Programs with the Endocrinology and Diabetes departments at Massachusetts General Hospital and The Children’s Hospital of Philadelphia in September 2022. Simone is actively involved in research and has a special interest in the management of diabetes in hospital and the implementation of innovative diabetes technology to support people with diabetes and their care team.
Promoting equitable access to continuous glucose monitoring for people with diabetes – an overview of the Austin Health – Continuous Glucose Monitoring (CGM) service.